Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(10%)
Results Posted
67%(4 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
1
10%
Ph not_applicable
1
10%
Ph phase_2
3
30%
Ph phase_4
5
50%

Phase Distribution

1

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
3(30.0%)
Phase 4Post-market surveillance
5(50.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 23 (30.0%)
Phase 45 (50.0%)
N/A1 (10.0%)

Trials by Status

terminated110%
unknown220%
recruiting110%
completed660%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10